6dishman

27'h Octobe

r, 2016

To,

The Manager,
Listing Department,
National Stock Exchange of lndia Ltd.
"Exchange Plaza" , C-1 , Block G,
Bandra-Kurla Complex,
Bandra (E), Mumbai - 400 051.
Ref.

: (i) Symbot- DTSHMAN

(ii) Series - Ee

To,

Department of Corporate Services

Bombay Stock Exchange Ltd.
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai - 400 001.

Ref. : i) Scrip Code No. : 532526

ii) Debt Scrip Code No. : 946682

SUB.: UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND

HALF YEAR ENDED
30/09/2016

REF.:

i) DlScLosuRE UNDER REGULATTON 30 AND REGULATTON 33 SEB| (L|ST|NG

oBLIGATION AND DISCLOSURE REQUIREMENTS) REGULATTONS, 2O1s

ii) OUR LETTER REGARDING REGULATION 29: INTIMATION OF BOARD

MEETING
DATED lBTH OCTOBER, 2016

Dear Sir,

As per Regulation 30-of sEBl (LODR) Regulations, 2015 we hereby

inform that a Meeting of the
Board of Directors of the Company was held today i.e. on l..1rriJav
zlii ocloo er, 2016 which
was commenced at'11 00AM and concluded at12'.40 PM at 301,3i0
Floor, "SamudraAnnexe,,,
Nr' Klassic Gold Hotel, Off. C. G. Road, Navrangpura, Ahmedabad 3gO
o0g, inter alia, to
consider and take on record the Unaudited FinanCial Results of
the company for the quarter
and half year ended. on 30th September, 2016, prepared in terms or
negutation 33 and 52 of
sEBl (Listing obtigation and Disclosure Requiremenis) Regulations, 2015.-

At the said Board Meetlng the said Unaudited Results were adopted
and approved, which are
attached
herewith.

Kindly take this on your record.

Thanking you.
Yours faithfully,

For, Dis

Pharmaceuticals and Chemicals Limited

Company Secretary
Encl.: As above

Registered

Dishmon Phormoceulicols ond Chemicols Limited

Office: Bhodr-Roi Chombers, Swoslik Cross Roods, Novrongpuro, Ahmedobod
Tel: +91 (0) 19 26443053

/ z644sgor

Fax:

*91

(o) 79 26420198

Emoil: dishmon@dishmongroup.com Web: www.dishmongroup.com

Governmenl Recognised Exporl House

CIN l..lo 124230G.r 1983p1C006329

3g0 009 lndio.

DISHMAN PHARMACETTICALS AND CHEMICALS LIMITED

CIN:L24230GJ1983PLC006329 EmaiilD:
Web : w.dishmangroup.com
Bhadr-Ral chambe6, swastik cross Roads, Navrangpura, Ahm6dabad-380 009 phone
No : 079-26443053 Fax No : 079-26420198
PaIt I : Statement of Unaudited Standalone , Consolidated Results for Quarter and Half yoar
Endod 30{9-20ro
lnuPsr! trt LrqrEs, tn lgn il[[9n
STANDALONE

Sr

lor

{o

$ales / tncome from operetions

he euaner ended
30.09-2016

rol

ne Precedtng

quarter ended
30{6-2016

ror

ne uorrespondln!

Quartsr ended
30.t)9-201 5

lz.9b

ror

rne Ha[ Year

nded
3049-20r6

6.77
10r

(0.45

;osts and exceptional items (1-2)

finre

Jther ln@me

(2.30

30.33

fininE-i6G

profiU(Lo33) trom ordinary activitles after financa

costs but
refors gxceptional items (5{)

.row(Loss, trom Ordinary Aclivities before tax

(7+g)

ax expense
yer proliu(Loss) for the period (9_10)

31.6r

21,74

19.76

53-35

48.60

57.08

26.4?

69.54

83.95

107.44

47.11

1U.5i

cu.c,

57.68

62.9

47.11

10.57

50-57

57.68

62.54

25.47

11

0.06
_ (o.oz

1't.i

rrotit, (Loss) lrom Operalions before Other lncome,

/ (Loss) from ordinary acttvitie- before

(8.'t7

1(

rnd amorlisalion exoense

ture

213-08

44.43

work-i;F;6EE;;;;a

retls expense

30-09.20r5

198.20

I slock-in-tmde
in inventories of finistreo g-oda,

Half Year ended

'11.70

37.75

8.42

38.87

46.17

46.69

37.75

8.42

38.87

4$.17

46,69

32.28

16.14

)s
14

{et Protit, (Loss) after taxes, minorlty lnterest ana strare of

rrofit/ (loss) of associats (,ll+12+.13)
rcome (Net of Tax)

11

19

Taxl (14+15)
-aro -up Equtry Dnare uaplat (hace value of Rs z- per equity
ihare)
Jasrc and Oiluted EPS (before & afrer Extraordinary ltems) (
ts. 2 ach)

tsasic EPS ( Not annualised)

Not annuatised)
ng notes to the financial results

0.83
32.28

32.28

16.14

of
2.89
0.52

iDAE,

+\>--.'1' ,/

",.9i*/

DISHMAN PHARMACEUNCALS

AND CHEMICALS LIMITED

CIN:L24230GJ1983PLC006329

EmaillD:dishman@dishmangr

Bhadr-Raj Chambe6, Swastlk Cross Roads, Navrangpura, Ahmedal

Part I : Staiement of Unaudited Standalone , Consolidated Results I

(Lo$) trom Operations before

Profit , (Loss) after taxes,

Share Capital (Face Value of Rs 2/- per

-"^"*

,.,. ,,./, '

:;":=1a".y'

+Y

bohalf of the

Ahmedabad
27th O6tober,

Chambers, Swastik Cross Roads, Navrangpura, Ahm6dabad_3Eo 009

I : Statement of Unaudited Standalone / Consolidated Results as at 30.{19-2016

Balance Sheet as

at 30th September,

2016

As at 30-09-2016

a) Property, plant and equipment

b) Capital work-in-progress

789.94

1,376.17

24.22

c) Goodwill

127.06
253.1

d) Other lntangible assets

1.60

e) Financial Assets
i) lnvestments
ii) Loans

165.93

25.26

58.82

39.32

iii) Others
f) Other non-cunent assets

a) lnventories
b) Financial Assets

i) lnvestments

16.09

?.16

2.16

139.68

1U.07

1,182.35

2,023.31

151.43

494.76

103.46

ii) Trade receivables

88.1

iii) Cash and cash equivalents

152.41

1.60

iv) Bank balances other than (iii) above

v) Loans

9.63

vi) Others
c) Curent Tax Assets (Net)

9.10
9.66

49.80

8.18

255.95

331.61

0.00

d) Other current assets

13.4e

EQUITY
(a) Share capitat
(b) Other equity

208.77

325.10

6.71

78.53

1.30

66.85

326.78

470.48

294.96

M6.45

1 1

a) Financial liabilities
i) Borrowings
ii) Trade payables
iii) Other financial liabilities
b) Other current liabilities
c) Provisions

'\g/

39.97

88.15

104.80

191.32

4.92

153.02

0.84

59.23

445.49

938.17

I
|

t
Notes:

'1

2'

The Financial results have been- reviewed by the Audit committee and
taken on record by the Board of oirectors at their
meetings hetd on 276 October, 2016.
Joint statutory Auditors have canied out a "Limited Review" of the standalone financial
result of the compahy for the quarter
'
and hatf year
gO"
ehded

3O'F

September, 2016 ano

Sept#bei,

loj6.-

The consolidated llnancial results for the quarter and half year ended 3o'september, 2016 ahd 3orh september, 2015 have
not been reviewed or audited and have been presenteo oaieo on itre intormaiion
comptieo ov 1fr"
making
the necessary adjustments to give a true and lair view ofthe resurts in accordance
with ind ASI

v*-"j".""i"fter

As,per Regulation 33 of sEBl (Listihg obligations and Disclosure Requirements) Regulation

20i5, the company has opted to
publish only consolidated financial resulti. The stand-alone financiil resulrs
are available for perusal on the company,s

website as well as on the slock exchanges, websites as stated below:

www.dishmanorouo.com, www.bseindii.com, and www. nseind ia. com.

As per lndian Accounting Standard ("lnd AS) 108

Consolidated Financial Result.

"Segment Reporting', segment information has been provided in

Consolidated financial results comprise the results of the parent Company, Dishman pharmaceuticals and Chemicals
Limited
rnc., Oistrman tnternationat rraOing lsrranjhai) bo. rto.,
AG, Switzerland, CARBOGEN AirClS (Shan;h;i) Co: Ltd. 6ormerly
known as Dishman Pharmaceuticals & Chemicals (Shanghai) Co. Ltd.l, Shanghai viqian triternati-onjt Trade Co.
Ltd.,
lnnovative ozone services rnc. (ro3s), Dishmn Netherlands ri. v.
ltormiirty knoin as.,iharma syn B. v,,,), Cotr""ie iine
,synfroi"" OCn
iqa!s_E y. (lolmgrly known as 'Dishman Ho and B.V.'), Carbogen Amcis Ltd.,U.K. (formerty kn;wn
9.h.ejn.
Ltd.)' CARBOGEN AMCIS AG, Switzerland, Carbogen Amcis (ndi;) Limited, Dishman Austratisia fty. r-t6.,
"" 6iJtrmin care
Ltd., CARBOGEN AMCIS SAS, Dishman Middle East (FZE), Dishman Japan Ljmited, and two associaie companies namely,
Schutz Dishman
L1d.(22.33o/o-holding by Dishman) and Bhadr-Raj Holdings Pvt. Ltd. (40% hotding by Dishman) as per
.Biotech
relevant Accounting Standards as at 30'September, 2016.

yj1 ?i"lrl?l Europe Limited., Dishman USA

ll-11"-:lb:i9?rl*
urshman swtzerland Limited,
Dishman Pharma Solutions

The Company adopted lndian Accounting Standard (lnd AS) from April 1, 2016 and accordingly these financiat results have
been prepared in accordance with the recognition and measuremeni principles laid down in ifii lnd As 34 interim Financial
Repodng prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued there under and the
other accounting principles generally accepted in lndia. Financial results Ior all the periods presented have been prepared in
accordance with the recognition and measurement principles of IND AS 34.
Reconciliation between financial results as previously repo(ed (referred to as "Previous GAAP') and lnd AS for quarter and
half year ended September 30, 2015 are as under:
tn

Particulars

Standalone

Net profit as per Previous GAAP

Consolidated

Quarter

HelfYear

ended
30.09.2015

ended

39.85

30.09.2015
47.85

Quarter
ended
30.09.2015
36.50

Half Year
ended
30.09.2015
74.26

Effect due to chanqe in classillcation of Leases

0.54

1.48

ffect of deferred tax on Intra-group transaction

1.44

-0.49

-0.42

-0.98

1.O7

1.30

-6.66

-5.62

Additional Depreciation due to recognition-iassets

retirernent obligation
lmpact of Foreign Exchange on Long Term Foreign
Currency Monetary lterns

-0.87

-1.31

-0.11

0.15

38.87

46.69

27.73

67.74

0.83

1.47

0.65

1.29

39.70

48.16

28.38

69.03

Additional Depreciation due to use of FairVatuation Ootion

Others
Net Profiu(Loss) for the period under lndAS
Other Comprehensive lncome
Total Comprehensive lncome under lnd AS

//./.'r'---'..
../..
/ -/"----\.\ \!L
l!,'' |
ll=i . ., ".""r)!ll
:

r;->/

0.39

10. As certain assets of the company including manufacturing facilities, development facilities and financial assets and liabilities
are often deployed interchangeably acrosJsegment, it isimpractical to allocate these assets and liabilities to each segment.
Hence, the details for capital employed have not been disclosed in the above table

ot SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 necessary

11. As per Regutation 52(4) and 54(2)
'listed
Non-ionvertible Redeemable Debentures are mentioned in Annexure - A attached
details/disciosures in ieipect of
herewith.

12. pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the aforesaid financial

Result may be iccessed on the Compan!'s we-bsite at www.dishmangroup.com and may also be accessed at the website of
the Stock Exchanges where the shares of the Company are listed at www.bseindia.com and www.nseindia.com.

13. The figures have been re-grouped, re-cast and re-ananged wherever considered necessary;

Place: Ahmedabad
Date: 27th October, 201 6

Annexure

-A

Disctosures pursuant to Regulation 52(4) and 54(21 ot SEBI (Listing Obligations and Disctosure Requirements)
2016:
Regulation zbrs in respect 6t ti"t"o ttoir-convertible Redeemable bebentures for the half year ended 30th september,
Details

Particulars

Sr.
No.

ereOit rating and change in credit

Asset cover available along with

2.

extent and nature

created

&

of

securitY

maintained in case of

non - convertible debt securities

Debt-Equity ratio
Previous due date for the Payment

3.

4.

of
M

interesV

@Ratingand

Research Pvt. Ltd.

(No change in the credit rating)

rating (if any)

CividFd--Jer---iq't1-

ffitures

("NCD") of the ComPanY

aggregating to Rs.22.50 crores as on September 30, 2016 are
secureO by way of first pari passu charge on the Company's
various properties and the asset cover thereof exceeds 1 00% of
the principal amount of the said debenture.

0.55

fm

cornp'any rras rnade payment of principal and interest up to

the previous due date being 18'n February, 20'16.

@
@

preferenee----+nares /non
convertible debt securities and

whether the same has been Paid

or not: and
Next due date for the Payment of

5.

interesU

@
@
iM
@
payablo
b.
8.

CividnC-_____f_4,r1_

and the redemption

Amount
Debt service coverage ratio
lnterest service coverage ratio
redeemable
preference shares (quantity and
value)
Capital redemption reserye/
debenture redemption reserve
(DRR)

Outstanding

lu.

Net Worth

11.
12.

Net Profit after tax

Earninqs per share

The next due date for payment of interest and principal of non
convertible debenture is 18tn February, 2017.

Next Redemption amount of NCD is Rs.22.50 crores along with

interest amount of Rs.2.33 crores.

1.23

4.06
Not Applicable

DRR - Rs.5.62 crores

Rs. 1083.55 crores

Rs.46.57 crores

Rs.2.86

The ratios have been computed on standalone basis as belowi

L OeUt Equity ratio= Total borrowings / Share Holder's Fund

It.

tll,

Debt service coverage ratio= Earning before interest, depreciation and Tax / (interest + Finance cost + repayment
made during the period)
lnterest service coverage ratio= Earning before interest, Depreciation and tax / lnterest expenses

+il

6oishman
27th October,

2016
To,

To,
The Manager,
Listing DePartment,
National Stock Exchange of lndia Ltd.
"Exchange Plaza" , C-1 , Block G,
Bandra-Kurla ComPlex,
Bandra (E), Mumbai - 400 051.

Ref.

Department of CorPorate Services

Bombay Stock Exchange Ltd.
Phiroze JeeieebhoY Towers,
Dalal Street,
Mumbai - 400 001.

Ref. : i) ScriP Code No. : 532526

ii) Debt ScriP Code No. : 946682

(i) Symbol- DISHMAN

( ii) Series - EQ

SUB.: REGULATION 33 & 52:SUBMISSIoNoFSTATUToRYAUDIToRS,LIMITED

REVIEW REPORT

OF BOARD MEETING
REF.: OUR LETTER REGARDING REGULATION 29: INTIMATION
DATED 18" ocroBER,2016
Dear Sir,

and Disclosure
As per the requirement of Regulation 33 and 52 of sEBl (Listing obligationAuditors' Limited
statutory
of
copy
a
Requirements) Regulations, 2015, we submit herewith
V. O. S6ufla & Co' and M/s Haribhakti
Review Report Ort"J iii^ October, 2016 signed by M/s.
the Company in respect of the
& Co. LLp, Chartered Accountants, Joint Statutory Auditors of
on 30th
Results of the Company for the quarter and half year ended
Unaudited Financial
September,2016.

was placed
we would like to inform you that the above referred Limited Review Report

before

the Board.
Kindly take the same on your record and oblige
Thanking you,
Yours faithfullY,
For, DishmAn Plarmaceuticals and Chemicals Limited

,<-rCv)/
-\\)-a/
.11"' -

'

'_ 1...

Stiiima oave

Company SecretarY
Encl.: As above

,,i;i
/:,,!

Dishmon Phormoceuticols ond Chemicols Limited

Novrongpuro, Ahmedobod
Regisiered o{{ice: Bhodr-Roi Chombers, Swosiik Cross Roods,

Tel:+91|o)7926443053/26445807tc'x:+91|o)7926420198
Emoil:dishmon@dishmqngroupcomWeb:www'dishmongroup'com
Governmenl Recognised Export House

clN NO

124230G1 I 983P1C00632?

380 009 lndio

Haribhakti & Co. LLP

V.D.Shukla & Co.

Chartered Accountants
22, Akruti Society,
Near Jodhpur Cross Roads,
Satettite,
Ahmedabad - 380 015.

Chartered Accountants
705, Leeta Business Park,
Andheri Kurta Road,
Andheri (East),
Mumbai - 400 059.

Limited Review Report

Review Report to
To

the Board of Directors

Dishman Pharmaceuticals and Chemicals Limited

1.

We have reviewed

the accompanying Statement of Unaudited Standatone Financial Results of

Dishman Pharmaceuticals and Chemicals Limited ('the Company') for the quarter ended
September 30,2016 ("the Statement"), being submitted by the Company pursuant

to the

requirement of Regulation 33 and Regulation 52 of the SEBI (Listing Obtigations and Disctosure

Requirements) Regulations, 2015 read

with Circutar No.

CIR/CFD/CMD/

15/2015 dated

November 30, 2015 and Circutar No. CIR/CFD/FAC/ 62/7016 dated July 5, 2016.
2.

This Statement which is the responsibitity of the Company's Management and approved by the

Board

of

Directors, has been prepared in accordance with recognition and measurement

principles laid down

in

lndian Accounting Standard 34 "lnterim Financial Reporting"

as

of Companies Act, 2013 ("the Act") read with retevant rules

issued there under and other accounting principles generalty accepted in lndia. our
prescribed under Section 133

responsibitity is to issue a report on the Statement based on our review.

3.

We conducted our review

in accordance with the Standard on Review Engagement

(SRE) 2410,

"Review of lnterim Financial lnformation Performed by the lndependent Auditor of the Entity"
issued by the lnstitute of Chartered Accountants of lndia. This standard requires that we ptan

and perform the review to obtain moderate assurance as to whether the Statement is free of

material misstatement. A review is timited primarity to inquiries of the Company personnel

and anatyticat procedures apptied to financial data and thus provide less assurance than an

audit. We have not performed an audit and accordingly, we do not express an audit opinion.

\. 1,:.

\.

4.

Based on our review conducted as above, nothing has come

to our attention that

causes us

to

betieve that the accompanying Statement, prepared in accordance with aforesaid accounting
standards and other recognized accounting practices and policies have not disctosed the

information required to be disclosed in terms of Regulation 33 and Regutation 52 of the

SEBI

(Listing Obtigations and Disclosure Requirements) Regutations, 7015 read with Circular No.
CIR/CFD/CMDI1512015 dated November 30, 2015 and Circutar No. CIR/CFDIFACI6?-12016

dated July 5, 2016, inctuding the manner in which

it is to be disctosed, or that it contains any

material misstatement.
5.

As stated

in Note 2 to the Statement, figures pertaining to the Standalone financial resutts of

the Company for the quarter and six months ended September 30, 2015 have been subjected

to limited review by us.

For Haribhakti & Co. LLP

For V.D.Shukta & Co.

Chartered Accountants

Chartered Accountants

lCAl Firm Registration No.103523W/W100048

lCAl Firm Registration No.1102

eu$
\<l

a, ,*,-

n t '*

iui'iDAI

M
Membership No.: 122071

Ahmedabad
October 27,2016

'-

/ul

Vimat D. Shukta
Partner
Membership No. :036416

':,"
--, i',ili.

c16ni6
110240UJ